CLS - Exercise period for TO3 subscription warrants has now started
Clinical Laserthermia Systems AB (publ) (“CLS” or the “Company”) carried out a rights issue of units (the “Rights Issue”) and a directed issue of units (the “Directed Issue”) in April 2021. The units issued in the Rights Issue and the Directed Share Issue consisted of shares and subscription warrants from the TO3 (the “Subscription Warrants”) and TO4 series. The exercise period for the TO3 subscription warrants started, April 11, 2022, and runs until April 25, 2022. One subscription warrant entitles the holder to subscribe for one (1) new class B share in CLS. The subscription price per share